Rebirth 90: I opened a hospital in Shencheng

Chapter 540 Occupying the market is in full swing!

Simultaneously.

The editor-in-chief of the medical department of the magazine also personally wrote an article to evaluate Nie Chen and the hepatitis C virus he developed.

"Nie Chen and I have known each other for a long time, and we can be regarded as old friends. Since he published the first paper in the magazine, I have given him all the papers that do not need to be verified. The reason is that his first paper The thesis convinced me, and I believe that the person who wrote such a rigorous thesis would not cheat!"

"Sure enough, Nie Chen's article on the development of the hepatitis C vaccine did not disappoint me. I don't care whether I doubt it or don't believe it, but this vaccine is real, and its effect has been confirmed by many scholars!"

"What I want to say is that it is not only hepatitis C, but other similar diseases can also be produced in this way. Nie Chen opened a door for us, a door to success. It is foreseeable that some people who have talked about it in the past The color-changing infectious disease will disappear in the future, and it won't be too long!"

"Nie Chen did not publish detailed data on the hepatitis C vaccine. In fact, this is understandable. Who can hand over hundreds of millions of profits to others!"

The editor-in-chief of the magazine supported Nie Chen.

What he valued was only the progress and development of medicine, and he didn't care much about the details of who owns the vaccine production technology.

With so many medical workers supporting Nie Chen, his popularity is getting higher and higher.

Many people began to understand the hepatitis C virus and his medical plan for hepatitis C patients.

Knowing that Qingwenbaidu powder and interferon can treat hepatitis C, many patients began to try it.

When more and more patients are successfully cured, they and their families are looking forward to the hepatitis C vaccine.

Many people have asked the authorities and Xinde Pharmaceutical to release the hepatitis C vaccine on the market as soon as possible.

Under such circumstances, the U.S. Food and Drug Administration (FDA) tried to contact Nie Chen and invited the hepatitis C vaccine produced by Xinde Pharmaceutical to be launched in the U.S. as soon as possible.

This is the first time that the U.S. Food and Drug Administration has issued such an invitation to foreign drug manufacturers, and the invitation letter has been published on its official website.

It is also helpless for them to do so.

There are too many people who want to put the hepatitis C vaccine on the market.

This is the end.

It is a certainty that the hepatitis C vaccine produced by Xinde Pharmaceutical will enter the U.S. market.

Nie Chen ordered the pharmaceutical factory to fully produce hepatitis C vaccine.

Sure enough, as he expected, the hepatitis C vaccine was a big seller as soon as it entered the market, and countless people were buying the hepatitis C vaccine for themselves and their families.

The partners of the pharmaceutical factory affiliated to the Medical University sold out the vaccine as soon as they received it, and stock outs often occur.

A few days later, the European Medicines Agency (EMEA) approved the marketing of hepatitis C vaccine in EU countries, which was also snapped up.

There are countless countries in contact with Nie Chen.

Gradually the hepatitis C vaccine developed into a routine vaccine.

A month later, Chinese officials finally approved the hepatitis C vaccine.

Secretary Chen's boss personally called Nie Chen.

"Congratulations. I originally thought that the hepatitis C vaccine was not easy for people to accept. It would take a few years to test it before it could be launched. I didn't expect it to be approved by the health department so soon!"

"But speaking of it, you really have made a face for our Huaxia. It is not easy to conquer all foreign medical experts and let them bow their heads to admit the effect of the vaccine!"

"Hepatitis C is a common and frequently-occurring disease in China, and its hidden dangers are extremely harmful!"

"I think the health department will pay more and more attention to the hepatitis C vaccine in the future, and it is likely to be used as a routine and necessary vaccine in the future!"

Secretary Chen's boss congratulated.

He knows how powerful it is.

If the hepatitis C vaccine is officially recognized and recommended, Nie Chen will not only get a steady stream of wealth but also a corresponding reputation and status.

"Thank you!"

"Thank you, leader!"

Nie Chen said gratefully.

The Hepatitis C vaccine can be approved and launched so quickly, thanks to the efforts of Secretary Chen's boss, Xinde Pharmaceutical, and even Shencheng Second Hospital.

Some are happy and some are sad.

When the hepatitis C vaccine was booming, several companies that owned the patent rights of Sophia Buwei caused heavy losses.

Although Sophie Bower has been on the market for less than ten years, it has earned tens of thousands of dollars in profits for each company.

Now that Nie Chen's treatment plan is out of nowhere and the hepatitis C vaccine is available, fewer and fewer people use Sophie Buwei.

The price of this sky-high drug has finally fallen. The price of the altar has dropped again and again.

From a price of one thousand dollars to less than one hundred dollars.

However, even in this way, there are not many patients who use this drug. Compared with the combination of Qingwenbaidu powder and interferon, the price of Sophie Buwei is still high.

Pfizer is also one of the companies that owns the manufacturing patent of Sophie Buwei.

Just because it took early precautions to reduce the price when Nie Chen's paper was published, the impact on the company was relatively small. Coupled with the profit support of other drugs, Pfizer Pharmaceuticals did not receive much impact.

Pioneer was different.

Previously, the company stepped into a difficult situation step by step. They regarded Sophie Buwei as a life-saving medicine, and waited for its profits to maintain the normal operation of the company.

Because of the failure of this drug, Pioneer also began the downfall of Slowman.

The company's stock price has been lowered again and again, and the turnover rate has hit a new high in a row, and almost every transaction is the lowest price.

Pioneer is over!

Completely finished!
This is a fact that many people have seen, and everyone is willing to tie up with this broken ship and sink to the bottom of the sea.

Shareholders are desperately selling Vanguard shares.

Pioneer fell into an unprecedented crisis when Xinde Pharmaceutical's hepatitis C vaccine was selling well.

The slow sales of Sophie Buwei caused serious problems in the company's capital chain.

Insufficient liquidity!

External debt increased!
The company entered a vicious circle.

Finally, it triggered a stock market crisis, and the shares of Pioneer fell rapidly.

"Ruined!"

"Sure enough, just like the nightmare I had before, the company's decline is as unstoppable as a snowball. There is no doubt that I must be responsible for this. There is no way the board of directors will let me go!"

"Xinde Pharmaceutical, Nie Chen! You are going to step on my corpse and climb up. I am not reconciled, I will not let it go!"

"I want you to pay the price!"

The new president of Pioneer Company roared in his heart.

He called the head of the technical department over and asked, "Now that we are at a critical point, the success or failure of our company depends on it. Think about it for me. Is it possible for us to make a comeback now?"

The head of the technical department fell silent.

Are there any eggs under the nest?

If Pioneer can't keep it, the technical director will definitely be affected.

From the bottom of his heart, the head of the technical department hoped that Pioneer would get better.

just.

How could he know marketing knowledge from a technical background?
The head of the technical department racked his brains to think of a strategy.

"President, I don't agree with lowering Sophie Buwei's price!"

"Even if we lower the price, can the price be lower than that of Xinde Pharmaceutical? They can treat hepatitis C with Qingwenbaidu powder and interferon, and the price is much lower than ours. At this point, we no advantage!"

"And when we jointly purchased the patents, we had an agreement with several other big pharmaceutical companies. We cannot unilaterally lower the drug price. If we breach the contract, we may have no way to explain it to other companies!"

The only way the technical department can think of is to lower the price of Sophie Buwei.

(End of this chapter)